Countries covered: United States
The U.S. point-of-care (POC) diagnostic test market is expected to reach revenues over $900 million in 2008, at a compound annual growth rate of 8.8%, due to technological advancements in POC testing equipment and continued market demand.
This report offers you the essential information needed to remain competitive in this highly evolving market. This study is designed to present the most up-to-date projections and data within the complex world of POC diagnostics. A thorough description of emerging products and conditions addressed as well as advancements in the U.S. market, Theta’s report will aid your organization by providing valuable market information.
This market research study analyses the POC market composition and dynamics, market size and participants, demographics, economic issues and regulatory issues are discussed. Historical market data are provided for each of the years 1998 through 2002, and forecast data are provided for each year 2003 through 2008.
Areas of POC testing covered in this report include:
- Infectious diseases
- Cardiac markers
- Coagulation
- Osteoporosis
- Drugs of abuse
- Miscellaneous rapid tests
An essential strategic resource, Theta’s Point-of-Care Testing: U.S. Markets and Progress provides the answers to the following questions:
- What new products are emerging in the POC test kit market?
- What effect are POC test kits having on the healthcare market in general, on physicians, on laboratories, etc.?
- How do end-users view the new test kits that are coming on the market?
- Who are the leading participants in the market?
Please Note: Theta requires that, for PDF orders, clients sign a confidentiality agreement prior to fulfillment of PDF email delivery.
|
1 Executive Summary
1.1 Scope and Objectives of Report
1.2 Methodology
1.3 U.S. Point of Care Diagnostics Market
1.4 Market Summary
2 Introduction and Overview
2.1 Regulations
2.2 Areas of Emerging Tests
2.3 Demographics
2.4 Types of Tests
2.4.1 Blood Tests
2.4.2 Hair Tests
2.4.3 Saliva Tests
2.4.4 Urine Tests
2.5 Conditions Evaluated by Testing
2.5.1 Alzheimer’s Disease
2.5.2 Cancer
2.5.3 Cardiac Conditions
2.5.4 Drug Abuse
2.5.5 Infectious Disease
2.5.6 Osteoporosis
3 Types of Tests and Manufacturers
3.1 Infectious Disease Testing
3.1.1 Chlamydia Tests
3.1.2 Cryptosporidium Species Tests
3.1.3 Genital Herpes Tests
3.1.4 Gonorrhea Tests
3.1.5 Hepatitis B and C Tests
3.1.6 HIV/AIDS Tests
3.1.7 H. Pylori Tests
3.1.8 Influenza Tests
3.1.9 Lyme Disease Tests
3.1.10 Mononucleosis Tests
3.1.11 Streptococcus Tests
3.1.12 Syphilis Tests
3.2 Cancer Testing
3.2.1 Colorectal Cancer
3.2.2 Bladder Testing
3.2.3 Prostate Cancer
3.3 Cholesterol Testing
3.4 Osteoporosis Testing
3.5 Rapid Cardiac Markers
3.6 Rapid Drug Testing
3.6.1 Alcohol Testing
3.6.2 Cocaine, Marijuana, Methamphetamine, Opiates Others
3.6.3 Tobacco Testing
3.7 Rapid Prothrombin Time
3.8 Miscellaneous Testing
4 Market Revenues and Forecast
4.1 Total Market
4.2 Infectious Disease Testing Market
4.3 Cancer Testing Market
4.4 Cholesterol Testing Market
4.5 Rapid Cardiac Marker Testing Market
4.6 Rapid Drug Testing Market
4.7 Rapid Prothrombin Time Testing
4.8 Miscellaneous Testing
5 Research and Development
5.1 Emerging Products and Companies
6 Competitive Analysis
7 Issues and Trends
7.1 Clinical Laboratory Improvement Amendments (CLIA)
7.2 POC Data Management
7.2 POC Tests and FDA Review
7.4 Medical Device Amendment
7.5 New Standards
7.6 Plug and Play Connectivity
7.7 Menu Expansion
7.8 Home Tests
8 Market Summary and Analysis
8.1 Market Summary
8.2 Market Analysis
9 Company Profiles
9.1 Abbott Laboratories
9.2 AccuTech, LLC
9.3 Applied Biotech, Inc.
9.4 Beckman Coulter, Inc.
9.5 Biomerica, Inc.
9.6 Biosafe Medical Technologies, Inc.
9.7 Biosite Diagnostics, Inc.
9.8 Cholestech Corp.
9.9 Dade Behring, Inc.
9.10 HemoSense, Inc.
9.11 International Technidyne Corp.
9.12 Lifestream Technologies, Inc.
9.13 Ostex International, Inc.
9.14 PharmaNetics, Inc.
9.15 Polymer Technology Systems, Inc.
9.16 Princeton BioMeditech Corp.
9.17 Psychemedics Corp.
9.18 Quidel Corp.
9.19 Roche Diagnostics Corp.
9.20 Spectral Diagnostics, Inc.
9.21 Sun Biomedical Laboratories, Inc.
9.22 Worldwide Medical Corp.
10 Company Directory
More United States Point-of-Care Reports
Innovative Technologies And Their Impact on the US Diagnostics Market by
Venture Planning Group
The next ten years will be marked by significant technological developments in health care and biotechnology, which will drastically change the assumptions and perceptions of ...
US Glucose Monitoring Market Analysis by
RNCOS
The US has a dominant share in the global diabetes market with 90-95% of the diabetic patients in the country suffering from type-II diabetes. Factors ...
Automated and Rapid Microbiological Tests by
Global Industry Analysts
This report analyzes the worldwide markets for Automated and Rapid Microbiological Tests in US$ Million by the following End-Use Segments: Clinical Applications (Automated Identification & ...
U.S. Market for In-Vitro Diagnostics 2011 (immunochemistry, molecular diagnostics, blood donor screening, hemostasis, hematology and point-of-care testing) by
iData Research, Inc.
By 2017, the U.S. in vitro diagnostic market is expected to approach $10 billion. The market segments covered in the U.S. Markets for In Vitro ...
Retail Clinics 2011: Growth of Stores, Best Venues, Winning Competitors, Supplier Sales of Products to Clinics, Clinic Sales Forecasts and Trends by
Kalorama Information
Convenience clinics, also known as retail health clinics, are a quickly growing segment of the U.S. health care marketplace, although their expansion has slowed somewhat ...
See all reports like this >>
More United States Reports
e-Discovery Software Publishing in the US - Industry Market Research Report by
IBISWorld
e-Discovery Software Publishing in the US Finding growth : Electronic discovery (more often known as e-discovery) refers to a data search, location and securing process for use ...
D&B Country RiskLine Report: The United States of America by
Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: The United States of America by
Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Country Report United States January 2011 by
Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
Coal - US - a snapshot (2010) by
Mintel - Snapshots
Coal in US by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2010. This market covers consumption ...
See all reports like this >>
Share this report
Other tasks Related Markets Point-of-Care Reports- 2012 Overview of the Laboratory and POC Hemostasis Diagnostic Markets: Facilities, Test Volumes, Sales Forecasts, and Key Player Market Shares
- 2012 World Hospital and Point-of-Care Coagulation Testing Market Outlook: Facilities, Test Volumes, Sales Forecasts, and Key Player Market Shares
- Point-of-Care Diagnostics - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018
- The 2012 Hematology and Flow Cytometry Instrumentation Review: Operating Characteristics, Features and Selling PricesOf 60 High-, Medium-, and Low-Volume/POC Analyzers
- The 2012 Global Overview of the Laboratory and POC Coagulation Testing Markets: Facilities, Test Volumes, Sales Forecasts, and Key Player Market Shares
Free Alert Me service Receive bi-weekly email alerts on new market research Sign Up Today!
|